Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Warshaw

Showing results (271-280 of 381) with videos related to

Pageof 39
Sort By:
Plos Biology|May 8, 2023
MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondiiAnne Kelsen, Robyn S Kent, Anne K Snyder, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 25, 2016
North American Contact Dermatitis Group Patch Test Results 2013-2014Joel G DeKoven, Erin M Warshaw, Donald V Belsito, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 14, 2018
North American Contact Dermatitis Group Patch Test Results: 2015-2016Joel G DeKoven, Erin M Warshaw, Kathryn A Zug, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 17, 2008
North American Contact Dermatitis Group patch-test results, 2003-2004 study periodErin M Warshaw, Donald V Belsito, Vincent A DeLeo, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 24, 2025
North American Contact Dermatitis Group Patch Test Results: 2021-2022Marie-Claude Houle, Joel G DeKoven, Amber Reck Atwater, et al.
Journal of the American Academy of Dermatology|July 4, 2008
The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004Kathryn A Zug, Robert L Rietschel, Erin M Warshaw, et al.
JAMA Dermatology|November 3, 2021
Importance of Supplemental Patch Testing Beyond a Screening Series for Patients With Dermatitis: The North American Contact Dermatitis Group ExperienceErin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 5, 2008
Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group, 2001 to 2004Kathryn A Zug, Rachel Kornik, Donald V Belsito, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 10, 2021
North American Contact Dermatitis Group Patch Test Results: 2017-2018Joel G DeKoven, Jonathan I Silverberg, Erin M Warshaw, et al.
Journal of Telemedicine and Telecare|May 14, 2013
Clinical course outcomes for store and forward teledermatology versus conventional consultation: a randomized trialJohn D Whited, Erin M Warshaw, Kush Kapur, et al.
Pageof 39

Showing results (271-280 of 381) with videos related to

Sort By:
Pageof 39
Plos Biology|May 8, 2023
MyosinA is a druggable target in the widespread protozoan parasite Toxoplasma gondiiAnne Kelsen, Robyn S Kent, Anne K Snyder, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|October 25, 2016
North American Contact Dermatitis Group Patch Test Results 2013-2014Joel G DeKoven, Erin M Warshaw, Donald V Belsito, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|November 14, 2018
North American Contact Dermatitis Group Patch Test Results: 2015-2016Joel G DeKoven, Erin M Warshaw, Kathryn A Zug, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 17, 2008
North American Contact Dermatitis Group patch-test results, 2003-2004 study periodErin M Warshaw, Donald V Belsito, Vincent A DeLeo, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|April 24, 2025
North American Contact Dermatitis Group Patch Test Results: 2021-2022Marie-Claude Houle, Joel G DeKoven, Amber Reck Atwater, et al.
Journal of the American Academy of Dermatology|July 4, 2008
The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004Kathryn A Zug, Robert L Rietschel, Erin M Warshaw, et al.
JAMA Dermatology|November 3, 2021
Importance of Supplemental Patch Testing Beyond a Screening Series for Patients With Dermatitis: The North American Contact Dermatitis Group ExperienceErin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|August 5, 2008
Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group, 2001 to 2004Kathryn A Zug, Rachel Kornik, Donald V Belsito, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 10, 2021
North American Contact Dermatitis Group Patch Test Results: 2017-2018Joel G DeKoven, Jonathan I Silverberg, Erin M Warshaw, et al.
Journal of Telemedicine and Telecare|May 14, 2013
Clinical course outcomes for store and forward teledermatology versus conventional consultation: a randomized trialJohn D Whited, Erin M Warshaw, Kush Kapur, et al.
Pageof 39